Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pennan M Barry

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Emerging Infectious Diseases|December 26, 2023
Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020Emily Han, Scott A Nabity, Shom Dasgupta-Tsinikas, et al.
Annals of the American Thoracic Society|March 1, 2018
Tuberculosis Mortality in the United States: Epidemiology and Prevention OpportunitiesSuzanne F Beavers, Lisa Pascopella, Amy L Davidow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2016
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2016
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
Open Forum Infectious Diseases|May 22, 2026
Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in CaliforniaShereen S Katrak, Rebecca C Wang, Chris E Keh, et al.
Lancet (London, England)|September 15, 2018
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis, Nafees Ahmad, Shama D Ahuja, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Emerging Infectious Diseases|December 26, 2023
Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020Emily Han, Scott A Nabity, Shom Dasgupta-Tsinikas, et al.
Annals of the American Thoracic Society|March 1, 2018
Tuberculosis Mortality in the United States: Epidemiology and Prevention OpportunitiesSuzanne F Beavers, Lisa Pascopella, Amy L Davidow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2016
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2016
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
Open Forum Infectious Diseases|May 22, 2026
Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in CaliforniaShereen S Katrak, Rebecca C Wang, Chris E Keh, et al.
Lancet (London, England)|September 15, 2018
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis, Nafees Ahmad, Shama D Ahuja, et al.
Pageof 5